Share: Facebook Twitter LinkedIn
Activity Provided By:

The France Foundation

Applying the Evidence on Antifibrotic Agents for IPF

Access Activity

Overview / Abstract:

These video-based roundtable discussions highlight key IPF updates provided at a recent annual meeting on pulmonary disease. Expert faculty reflect on new information on IPF and discuss the impact it has on patients.

Expiration

Jun 11, 2018

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Webinar / Webcast / Video

Credits / Hours

0.5 AMA PRA Category 1 Credit(s)™

Accreditation

The France Foundation

Presenters / Authors / Faculty

David J. Lederer, MD, MS
Fernando J. Martinez, MD, MS

Sponsors / Supporters / Grant Providers

Genentech

Keywords / Search Terms

The France Foundation Pulmonary, IPF, Pirfenidone, Genentech Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map